CatSci Secures Major £4.5m Funding Deal

CatSci Secures Major £4.5m Funding Deal

16th March 2022

CatSci Ltd, a scientifically-led, commercially-minded and award-winning innovation partner for medicines development, has secured £4.5m of investment from the alternative lender BOOST&Co to expedite the development and launch of life-changing therapeutics.

Shaw & Co, the specialist corporate finance advisory firm, advised CatSci on the deal which will be used to fund the strategic expansion of its workforce, laboratories, equipment and offerings.

Established in 2011, CatSci now employs nearly 100 people and achieved a turnover of more than £5.8m in 2021. The company develops economically and environmentally sustainable drug manufacturing processes that enable its global pharmaceutical customers to create affordable small molecule therapeutics to address critical public health challenges, including antimicrobial resistance, cancer and mental health.

The £4.5m funding will be a continuation of CatSci’s £3m investment – started in 2021 – whilst helping to refinance the company’s existing debt. New equipment and a major extension to its 13,000 sq ft laboratories in Cardiff will support CatSci’s expansion of its capabilities in chemical and analytical development, material science, and product formulation, alongside GMP Analytical testing. This will enable CatSci to continue offering “more and better” to its customers so that they can deliver best-in-class medicines to patients worldwide.

Dr Ross Burn, Chief Executive Officer at CatSci, said: “It was our pleasure to work with Shaw & Co to source significant growth capital from BOOST&Co to complete our 2022 investment plan. Expanding our chemistry facilities in Cardiff and establishing our GMP Analytical facility in London are pivotal steps of our journey to become a fully integrated CMC (Chemistry, Manufacturing and Control) innovation partner that accelerates medicines development. ”

Chris Mears, Principal at BOOST&Co said: “CatSci is a world-class and agile innovation partner in an increasingly vital sector. This investment will help fuel the growth plans in providing new state-of-the art laboratories and highly skilled job opportunities as well as continuing to enhance South Wales’ reputation as a hot-bed of innovation and expertise.

“We quickly gained confidence in the capability of this management team and their ability to continue their scale-up journey. The focus at BOOST&Co to buy into future plans rather than pure historics and to provide a higher debt amount than a main-stream lender was key to supporting these expansion plans effectively.”

Colin Burns, Director at Shaw & Co said: “We ran a competitive marketing process across a wide variety of traditional and alternative lenders to find CatSci the best possible deal which would provide them with a strong foundation for further growth. The deal demonstrates that there are certainly a number of viable financing options out there for any SME looking to fund their company’s future development and expansion.”

© CatSci Ltd, 2022.

For more information, including media enquiries, please contact:

CatSci Ltd

Dr. Sofia C. Papadouli
Tel: +44 29 2083 7444
Email: sofia.papadouli@catsci.com

 

Discover More About CatSci’s Material Science Capabilities Here:

CatSci commissions new material science lab as part of ambition to integrate medicines development